Annual CAPEX
$218.00 K
-$674.00 K-75.56%
December 31, 2023
Summary
- As of March 10, 2025, MTNB annual capital expenditures is $218.00 thousand, with the most recent change of -$674.00 thousand (-75.56%) on December 31, 2023.
- During the last 3 years, MTNB annual CAPEX has risen by +$212.30 thousand (+3724.56%).
- MTNB annual CAPEX is now -76.86% below its all-time high of $942.20 thousand, reached on December 31, 2017.
Performance
MTNB CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
N/A
September 30, 2024
Summary
- MTNB quarterly capital expenditures is not available.
Performance
MTNB Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
September 30, 2024
Summary
- MTNB TTM capital expenditures is not available.
Performance
MTNB TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
MTNB CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -75.6% | - | - |
| 3 y3 years | +3724.6% | - | - |
| 5 y5 years | -59.3% | - | - |
MTNB CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -75.6% | at low | ||||
| 5 y | 5-year | -75.6% | +3724.6% | ||||
| alltime | all time | -76.9% | +3724.6% |
Matinas BioPharma Holdings CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $218.00 K(-75.6%) | - | - |
| Dec 2022 | $892.00 K(+243.1%) | $42.00 K(-83.2%) | $892.00 K(+0.7%) |
| Sep 2022 | - | $250.00 K(+354.5%) | $885.80 K(+3.0%) |
| Jun 2022 | - | $55.00 K(-89.9%) | $860.00 K(+6.8%) |
| Mar 2022 | - | $545.00 K(+1422.3%) | $805.00 K(+209.6%) |
| Dec 2021 | $260.00 K(+4461.4%) | $35.80 K(-84.0%) | $260.00 K(+16.0%) |
| Sep 2021 | - | $224.20 K(>+9900.0%) | $224.20 K(+3833.3%) |
| Dec 2020 | $5700.00(-98.6%) | $0.00(0.0%) | $5700.00(0.0%) |
| Sep 2020 | - | $0.00(0.0%) | $5700.00(-92.8%) |
| Jun 2020 | - | $0.00(-100.0%) | $79.10 K(-80.1%) |
| Mar 2020 | - | $5700.00(>+9900.0%) | $397.00 K(-2.1%) |
| Dec 2019 | $405.60 K | $0.00(-100.0%) | $405.50 K(0.0%) |
| Sep 2019 | - | $73.40 K(-76.9%) | $405.50 K(-33.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $317.90 K(+2138.7%) | $607.40 K(+35.5%) |
| Mar 2019 | - | $14.20 K(>+9900.0%) | $448.20 K(-16.4%) |
| Dec 2018 | $535.90 K(-43.1%) | $0.00(-100.0%) | $535.90 K(-18.1%) |
| Sep 2018 | - | $275.30 K(+73.5%) | $654.20 K(+58.4%) |
| Jun 2018 | - | $158.70 K(+55.7%) | $413.10 K(-60.4%) |
| Mar 2018 | - | $101.90 K(-13.9%) | $1.04 M(+10.8%) |
| Dec 2017 | $942.20 K(+1136.5%) | $118.30 K(+245.9%) | $942.20 K(+14.4%) |
| Sep 2017 | - | $34.20 K(-95.7%) | $823.90 K(+4.3%) |
| Jun 2017 | - | $789.70 K(+3348.5%) | $789.70 K(+937.7%) |
| Dec 2015 | $76.20 K | $22.90 K(+57.9%) | $76.10 K(+43.0%) |
| Sep 2015 | - | $14.50 K(-57.2%) | $53.20 K(+37.5%) |
| Jun 2015 | - | $33.90 K(+606.3%) | $38.70 K(+706.3%) |
| Mar 2015 | - | $4800.00 | $4800.00 |
FAQ
- What is Matinas BioPharma Holdings annual capital expenditures?
- What is the all time high annual CAPEX for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for Matinas BioPharma Holdings?
- What is the all time high TTM CAPEX for Matinas BioPharma Holdings?
What is Matinas BioPharma Holdings annual capital expenditures?
The current annual CAPEX of MTNB is $218.00 K
What is the all time high annual CAPEX for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual capital expenditures is $942.20 K
What is Matinas BioPharma Holdings annual CAPEX year-on-year change?
Over the past year, MTNB annual capital expenditures has changed by -$674.00 K (-75.56%)
What is the all time high quarterly CAPEX for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly capital expenditures is $789.70 K
What is the all time high TTM CAPEX for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high TTM capital expenditures is $1.04 M